Delpharm

Delpharm describes itself as a leading CDMO among the main global players in the CDMO sector, specialized in the development and manufacturing of medicines for the pharmaceutical industry. It reports a network of plants located in Europe and North America and states that the group is durably positioned in the top 5 of international CDMOs. Its expertise covers solid, sterile, semi-solid and liquid forms. It reports 18 production sites, 3 development centers, €1.1 billion in revenue, top 5 worldwide, and 6,500 employees. Its history page states that Delpharm was built over the years through the acquisition of production plants from major pharmaceutical laboratories, and that 100% of its activity is dedicated to pharmaceutical product development and manufacturing of medicines for third parties.

Delpharm states that it was built over the years through the acquisition of production plants from major pharmaceutical laboratories. These acquisitions allowed it to offer more dosage forms to its clients and capacities that make Delpharm one of the very first European CDMOs, with 1 billion boxes of medicines produced per year. It also states that 100% of its activity is dedicated to pharmaceutical product development and manufacturing of medicines for third parties. Its chronology mentions the acquisition of the Meppel site (Netherlands), ex Astellas, specialized in oral solid dosage forms, with FDA certification strengthening its position for delivery to the USA market; the 2023 acquisition of a development center in Leiden (Netherlands) specialized in sterile injectable forms; the 2022 acquisition of the Boucherville site (Canada), ex Novartis, enabling production of sterile bottles and ampoules in North America; the 2021 acquisition of the Poznań site, ex GSK, adding highly active soft capsules to its portfolio; and the creation of DELPHARM ACADEMY in 2021.

Delpharm figures among the main global players in the CDMO sector and states it is durably positioned in the top 5 of international CDMOs.

1. 1Delpharm - Fabrication développement de médicaments CDMOdelpharm.com
2. 2L'histoire de Delpharmdelpharm.com